Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

MIT biologists discover cellular pathway that triggers colon cancer spread (opens in a new tab)

news-medical.net · 2026-09-24

Short answerEvidenceSource

Short answer

Not supported

Not supported.

2 claims go further than the study. 3 other points were not covered by the paper.

  • 2 overstated
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Not supported

Two of five claims overstate the study. Three claims the study doesn't address.

  • 2 overstated
  • 3 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5OverstatedA high-fat diet is more likely to turn on the pathway through production of ceramides, and drugs that block ceramide production could help prevent metastasis in colon cancer.View evidenceHide evidence

Why this verdict

The abstract profile supports a causal experimental chain in which dietary fat exposure increases tumor-intrinsic de novo ceramide biosynthesis and promotes YAP-linked metastatic capability. It also supports that Degs1 loss reduces ceramide, YAP activity, and metastasis. But the claim’s headline-prominence translational statement that drugs blocking ceramide production could help prevent metastasis outruns the abstract evidence: the profile describes genetic/metabolic perturbations in basic models, not demonstrated preventive drug efficacy in patients or even a clearly specified drug-blockade-of-synthesis experiment at abstract depth.

1

Study evidence

Dietary fat exposure triggers a sustained tumor-intrinsic increase in de novo ceramide biosynthesis mediated by Degs1, which is reported to initiate colorectal cancer metastasis in vivo.

“dietary fat exposure triggers a sustained increase in de novo ceramide biosynthesis”
2

Study evidence

Loss of Degs1 reduced tumor ceramide levels (reported in abstract).

“mediated by the dihydroceramide desaturase Degs1”
Claim 2 of 5OverstatedMIT biologists identified a cellular pathway necessary for colorectal cancer metastasis.View evidenceHide evidence

Why this verdict

The abstract-level profile supports a causal pathway in which dietary-fat-amplified ceramide biosynthesis, YAP activation, and a YAP-driven/Basp1-high state promote or initiate metastatic capability in experimental colorectal cancer models. However, the story’s lead claim that the pathway is generally “necessary for colorectal cancer metastasis” is broader and stronger than the abstract evidence, which reports reduced or prevented metastatic seeding under specific perturbations and does not establish universal necessity across colorectal cancer.

1

Study evidence

Dietary fat exposure triggers a sustained tumor-intrinsic increase in de novo ceramide biosynthesis mediated by Degs1, which is reported to initiate colorectal cancer metastasis in vivo.

“dietary fat exposure triggers a sustained increase in de novo ceramide biosynthesis”
2

Study evidence

Loss of Degs1 reduced tumor ceramide levels (reported in abstract).

“mediated by the dihydroceramide desaturase Degs1”
Claim 3 of 5Not coveredThe pathway is controlled by YAP1, which normally helps with tissue repair, but when activated in cancer cells it promotes cell proliferation and migration.View evidenceHide evidence

Why this verdict

The abstract profile supports that ceramide accumulation activates YAP via PP2A-mediated dephosphorylation and induces a YAP-driven regenerative program. But the supplied abstract-depth evidence does not verify the story’s added statements that YAP1 normally helps tissue repair or that activation in cancer cells specifically promotes proliferation and migration. Those details may exist in the full paper or background, but they are not verifiable from the supplied abstract-level profile.

1

Study evidence

Ceramide accumulation activates YAP through PP2A-mediated dephosphorylation.

“Ceramide accumulation activates yes-associated protein (YAP) through protein phosphatase 2A (PP2A)–mediated dephosphorylation”
2

Study evidence

Ceramide accumulation activates YAP through PP2A-mediated dephosphorylation, promoting a durable shift toward a distinct YAP-driven regenerative (YAP-DR) transcriptional program marked by Basp1.

“promoting a durable shift toward a distinct YAP-driven regenerative (YAP-DR) program, marked by Basp1”
Claim 4 of 5Not coveredIn mouse studies, genetically targeting YAP1 or genes involved in ceramide production markedly reduced the spread of colon cancer to the liver.View evidenceHide evidence

As statedmarkedly reduced

Why this verdict

The abstract profile supports that Degs1 loss reduced ceramide levels, YAP activity, YAP-DR signatures, and metastasis, and that eliminating Basp1-high cells prevented metastatic seeding. However, the supplied abstract-depth profile does not verify several specifics in the story claim: direct genetic targeting of YAP1, liver as the metastatic site, mouse-study details, or the magnitude term “markedly reduced.”

1

Study evidence

Loss of Degs1 reduced tumor ceramide levels (reported in abstract).

“mediated by the dihydroceramide desaturase Degs1”
2

Study evidence

Selective elimination of Basp1-high cancer cells prevented metastatic seeding.

“Selective elimination of Basp1 high cancer cells prevented metastatic seeding.”
Claim 5 of 5Not coveredIn human RNA sequencing data, YAP1 was more active in metastatic cancer cells, and patients with higher BMI showed higher expression of YAP1-activated genes and lower survival rates.View evidenceHide evidence

Why this verdict

The supplied paper profile is abstract-depth and contains no appraised human RNA-sequencing, BMI-stratified expression, metastatic-cell YAP1-activity, or survival-analysis evidence. The claim may reflect full-paper patient-data analyses, but it is not verifiable from the provided abstract-level profile.

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The YAP-driven regenerative program is marked by Basp1, and selective elimination of Basp1-high cancer cells prevented metastatic seeding.

    The story presentation does not mention Basp1, the Basp1-high cell state, or the specific experiment in which selective elimination of Basp1-high cells prevented metastatic seeding.

    From transcriptomic profiling and marker validation (abstract-level); in_vivo ablation/depletion of Basp1-high cells

  • Blocking ceramide degradation enhanced YAP activity and metastasis, supporting ceramide metabolism as a regulator of the metastatic program.

    The story emphasizes blocking ceramide production as potentially therapeutic, but does not report the complementary abstract finding that blocking ceramide degradation increased YAP activity and metastasis.

    From in vivo pharmacologic inhibition of ceramide degradation

4 things the story did carry across
  • Dietary fat exposure amplifies tumor-intrinsic de novo ceramide biosynthesis, mediated by Degs1, and is reported to initiate colorectal cancer metastatic capability in vivo.
  • Ceramide accumulation activates YAP through PP2A-mediated dephosphorylation, leading to a YAP-driven regenerative program.
  • Degs1 loss reduced ceramide levels, YAP activity, YAP-DR signatures, and metastasis without affecting primary tumor growth.
  • The paper evidence is primarily basic/mechanistic and preclinical for the diet–ceramide–YAP metastasis pathway; patient-directed dietary or drug-prevention implications require further evidence.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

6

Evidence read

study summary

Lead result

in vivo animal

1Lead resultin vivo animalDietary fat amplifies tumor-intrinsic de novo ceramide biosynthesis (via Degs1), which initiates colorectal cancer metastatic capability.in vivo diet manipulation and metastasis assaysExpand

In plain English

In vivo (animal) experiments reported in the abstract indicate that dietary fat exposure provokes a sustained, tumor-intrinsic increase in de novo ceramide biosynthesis mediated by Degs1, which promotes YAP activation and initiates colorectal cancer metastatic capability; genetic loss of Degs1 reduced ceramide, YAP signaling and metastasis without affecting primary tumor growth.

Key findings

  • Dietary fat exposure triggers a sustained tumor-intrinsic increase in de novo ceramide biosynthesis mediated by Degs1, which is reported to initiate colorectal cancer metastasis in vivo.
  • Loss of Degs1 reduced tumor ceramide levels, decreased YAP activity and YAP-DR transcriptional signatures, and reduced metastasis without altering primary tumor growth (supporting a tumor-intrinsic role for Degs1-driven ceramide in metastasis).
“dietary fat exposure triggers a sustained increase in de novo ceramide biosynthesis”
What this piece can’t prove
  • Summary is based solely on the abstract; the abstract does not report species/strain, sample sizes, diet composition, duration of dietary exposure, or statistical measures.

3 further details could not be confirmed from the summary.

2in vivo animalDietary fat amplifies tumor-intrinsic de novo ceramide biosynthesis (via Degs1), which initiates colorectal cancer metastatic capability.Degs1 loss-of-function perturbation (in vivo)Expand

In plain English

In vivo loss-of-function perturbation of Degs1 reduced tumor ceramide levels, attenuated YAP activity and a YAP-driven regenerative transcriptional program, and decreased metastatic seeding without changing primary tumor growth; dietary fat was reported to amplify Degs1-dependent de novo ceramide biosynthesis that drives YAP activation.

Key findings

  • Loss of Degs1 reduced tumor ceramide levels (reported in abstract).
  • Degs1 loss decreased YAP activity and a YAP-driven regenerative (YAP-DR) transcriptional signature (reported in abstract).
“mediated by the dihydroceramide desaturase Degs1”
What this piece can’t prove

3 further details could not be confirmed from the summary.

3in vitroCeramide accumulation activates YAP through PP2A-mediated dephosphorylation, inducing a durable YAP-driven regenerative (YAP-DR) program marked by Basp1 that promotes metastasis.in vitro biochemical assays (implied)Expand

In plain English

The abstract reports that ceramide accumulation activates yes-associated protein (YAP) via protein phosphatase 2A (PP2A)–mediated dephosphorylation, and that this activation induces a durable YAP-driven regenerative (YAP-DR) transcriptional program marked by Basp1. The statement is presented as a mechanistic link in the paper abstract and implies cell-based biochemical evidence for PP2A-dependent regulation of YAP phosphorylation and activity.

Key findings

  • Ceramide accumulation activates YAP through PP2A-mediated dephosphorylation.
  • YAP activation induces a durable YAP-driven regenerative (YAP-DR) program marked by Basp1.
“Ceramide accumulation activates yes-associated protein (YAP) through protein phosphatase 2A (PP2A)–mediated dephosphorylation”
What this piece can’t prove
  • Causal inference (PP2A-mediated dephosphorylation) is stated but the abstract does not specify the perturbation approach used to establish PP2A dependence.

3 further details could not be confirmed from the summary.

4otherCeramide accumulation activates YAP through PP2A-mediated dephosphorylation, inducing a durable YAP-driven regenerative (YAP-DR) program marked by Basp1 that promotes metastasis.transcriptomic profiling and marker validation (abstract-level)Expand

In plain English

The abstract reports that ceramide accumulation activates YAP via PP2A-mediated dephosphorylation and that this activation produces a durable shift to a distinct YAP-driven regenerative (YAP-DR) transcriptional program that is marked by Basp1. The YAP-DR/Basp1-high state is implicated in promoting metastasis, and selective elimination of Basp1-high cancer cells prevented metastatic seeding.

Key findings

  • Ceramide accumulation activates YAP through PP2A-mediated dephosphorylation, promoting a durable shift toward a distinct YAP-driven regenerative (YAP-DR) transcriptional program marked by Basp1.
  • Selective elimination of Basp1-high cancer cells prevented metastatic seeding, supporting a functional role for the Basp1-marked YAP-DR state in metastasis.
“promoting a durable shift toward a distinct YAP-driven regenerative (YAP-DR) program, marked by Basp1”
What this piece can’t prove
  • Summary is based solely on the abstract; primary-paper methods, data, and quantitative results are not available in this unit.
  • Abstract does not specify the transcriptomic platform (bulk RNA-seq vs. single-cell RNA-seq), sample sizes, replicates, or statistical thresholds used to define the YAP-DR signature.

2 further details could not be confirmed from the summary.

5in vivo animalTargeting the YAP-DR state (e.g., eliminating Basp1-high cancer cells) prevents metastatic seeding, and manipulating ceramide synthesis/degradation modulates YAP activity and metastasis independently of primary tumor growth.in vivo ablation/depletion of Basp1-high cellsExpand

In plain English

The paper reports that selective elimination of Basp1-high cancer cells prevented metastatic seeding in vivo, indicating that the YAP-driven regenerative (YAP-DR) Basp1-high cell state is functionally required for metastatic initiation. The abstract does not provide details on the elimination method, experimental model, or quantitative effect sizes.

Key findings

  • Selective elimination of Basp1-high cancer cells prevented metastatic seeding.
“Selective elimination of Basp1 high cancer cells prevented metastatic seeding.”
What this piece can’t prove
  • Unclear whether elimination of Basp1-high cells affected primary tumor growth in these experiments or only metastatic seeding (abstract does not specify for this intervention).

2 further details could not be confirmed from the summary.

6in vivo animalTargeting the YAP-DR state (e.g., eliminating Basp1-high cancer cells) prevents metastatic seeding, and manipulating ceramide synthesis/degradation modulates YAP activity and metastasis independently of primary tumor growth.in vivo pharmacologic inhibition of ceramide degradationExpand

In plain English

The paper reports that blockade of ceramide degradation (pharmacologic inhibition) led to increased YAP activity and enhanced metastatic outcomes in vivo.

Key findings

  • Pharmacologic blockade of ceramide degradation increased YAP activity and promoted metastasis in the reported experimental system.
“blocking ceramide degradation enhanced YAP activity and metastasis”
What this piece can’t prove
  • Unclear whether primary tumor growth was assessed in the ceramide-degradation blockade experiments (the abstract reports primary tumor–independence for Degs1 loss but does not explicitly state this for degradation blockade).
  • Specificity of the pharmacologic blockade for ceramide degradation enzymes and potential confounding systemic lipid changes are not reported.

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Ceramide synthesis mediates colorectal cancer metastasis through a YAP-driven regenerative program

Science · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, Europe PMC, PubMed · 38 candidate papers

Selected

Ceramide synthesis mediates colorectal cancer metastasis through a YAP-driven regenerative program

Science · 2026 · Crossref

Source (opens in a new tab)
Candidate

Author comment: Floating solar systems for clean energy: Addressing humidity-induced corrosions — R1/PR8

2026 · Crossref

Source (opens in a new tab)
Candidate

Author comment: Floating solar systems for clean energy: Addressing humidity-induced corrosions — R0/PR1

2026 · Crossref

Source (opens in a new tab)
Candidate

Author Correction: A brief history of Asian summer monsoon evolution in the Cenozoic era

Npj Climate and Atmospheric Science · 2026 · Crossref

Source (opens in a new tab)

And 32 more candidates considered.